Abbott Begins Early International Launch of XIENCE™ Everolimus Eluting Coronary Stent System

Abbott Begins Early International Launch of XIENCE™ Everolimus Eluting Coronary Stent System

“XIENCE V showed statistically significant superiority to the TAXUS® paclitaxel-eluting coronary stent system”.
Related post here

Bookmark and Share

2 Responses to “Abbott Begins Early International Launch of XIENCE™ Everolimus Eluting Coronary Stent System”

  1. sayed shafiul alam March 25, 2007 at 13:07 #

    Looking cardiac interventional product for distributorship in bangladesh.

  2. sayed shafiul alam March 25, 2007 at 13:12 #

    I want to know what is your companys terms& condition for distributor in bangladesh.

Leave a Reply